Concepedia

Leonard Post

LP

Statistics

Publications

1

Citations

21

H-Index

1

Active since

2022

Affiliations

Mateon Therapeutics (United States)(Current)

Leonard Post is an author at Mateon Therapeutics (United States) specializing in tumor biology, cancer therapeutics, and oncology.

Top concepts

Publications per year

2022–2022

1

Publications

1

Abstract 5364: The TEAD autopalmitoylation inhibitor VT3989 improves efficacy and increases durability of efficacy of osimertinib in preclinical <i>EGFR</i> mutant tumor models

Tracy T. Tang, Leonard Post · Cancer Research · 2022 · 21 citations

, , +18

1–1 of 1